High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)
Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical efficacy of high-dose methotrexate
consolidation therapy for adult patients with BCR-ABL-negative ALL.